Metastatic brain tumors
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients having metastatic brain tumors treated with staged gamma knife radiosurgery until end of December 2015. The included patients meet the following criteria: 1) newly diagnosed brain metastases 2) maximum total treatment period of 6 weeks 3) minimum interval between fractions of 12 days 4) Prescribed dose 9-11 Gy for 3 staged or 11.8-14.3 Gy for 2 staged gamma knife radiosurgery 5) KPS more than and equal to 70, or KPS less than 70 due to neurological symptom 6) maximum volume of 33.5 cm3 7) up to 10 brain tumors 8) maximum total tumor volume of 50 cm3 9) patient's head secured with Leksel G frame 10) no finding of meningeal seeding or carcinomatous meningitis on MRI 11) one or more available follow-up MRI
Exclusion criteria
Exclusion criteria: Patients with brain tumors of unknown origin, brain metastases of sarcoma, malignant lymphoma are excluded in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall survival | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Functional preserved survival 2) Additional treatments 3) Local tumor control 4) Treatment-related adverse events | — |
Countries
Japan
Contacts
Chiba University Graduate School of Medicine Department of Neurological Surgery